Propranolol furosemide for treatment of advanced hepatocellular carcinoma and liver metastases with ascites observation.doc

 PAGE \* MERGEFORMAT 5 Propranolol furosemide for treatment of advanced hepatocellular carcinoma and liver metastases with ascites observation Author: Li Ying, Li Miao, Di Yanhui, Guan, Chin Hung [Keywords:] advanced liver cancer; liver metastases; ascites; propranolol; furosemide [Abstract] Objective of advanced liver cancer and liver metastasis, multi-ascites, treatment more difficult. The author in the anti-cancer, correcting water, electrolyte disorder and hypoproteinemia, based on the observation of propranolol and furosemide treatment effect. Methods 54 patients routine examination to exclude, after heart disease and give oral propranolol 10 mg, 3 times / d; furosemide 20 mg, 3 times / d. Daily measurement of abdominal circumference and record urine output, periodic inspections of water, electrolyte, adequate potassium supplement to correct hypoproteinemia. 1 week used in conjunction to effectively continue to be used until after a month out with no response. Results Among 54 patients improved in 12 cases, effective in 26 cases, effective in 8 cases, 8 cases, the total effective rate 85.2%. Conclusion of propranolol and furosemide in patients with advanced liver cancer and liver metastasis, ascites, portal hypertension can be reduced to alleviate the ascites, and no special side effects, should continue to study. [Keywords:] advanced liver cancer; liver metastases; ascites; propranolol; furosemide Propranolo and furosemide in treatment of advanced hepatocarcinoma and meta static carcinoma with ascites [Abstract] Objective It’s difficult to treat the ascites in hepatocarcinoma or liver metastatic carcinoma patients.We observed the circumstance of ascites of 54 hepatocarcinoma or liver metastatic carcinoma patients, who received propranolol and furosemide besides anticancer therapy, rectifying the abnormal electrolyte and hypoproteinemia, and obtained the good effect.Methods 54 patients without cardiovascular diseases were given propranolol at the dos